IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1038/ncomms9746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
- (2015) Zhaoyang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
- (2014) Laura Tornatore et al. CANCER CELL
- Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
- (2014) Thanh U. Barbie et al. JOURNAL OF CLINICAL INVESTIGATION
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
- (2014) Antonina V. Kurtova et al. NATURE
- A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
- (2014) Haihui Lu et al. NATURE CELL BIOLOGY
- A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis
- (2014) Ferenc A. Scheeren et al. NATURE CELL BIOLOGY
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade
- (2014) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells
- (2013) Fabio Petrocca et al. CANCER CELL
- Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
- (2013) Wai Leong Tam et al. CANCER CELL
- Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
- (2013) Garrett W. Rhyasen et al. CANCER CELL
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4
- (2012) R. Srivastava et al. CANCER RESEARCH
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammation
- (2011) Eun-Ha Joh et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
- (2011) H. Korkaya et al. CLINICAL CANCER RESEARCH
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- The Canonical NF- B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
- (2010) M. Liu et al. CANCER RESEARCH
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Complex-Mediated Cell Activation from Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients Elaborate Different Requirements for IRAK1/4 Kinase Activity across Human Cell Types
- (2010) E. Y. Chiang et al. JOURNAL OF IMMUNOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
- (2009) M Murohashi et al. BRITISH JOURNAL OF CANCER
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Cancer Stem Cells in Cancer Prevention and Therapy
- (2008) Prithi Rajan et al. Stem Cell Reviews and Reports
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started